Tamarack Advisers, LP - CORREVIO PHARMA CORP ownership

CORREVIO PHARMA CORP's ticker is CORV and the CUSIP is 22026V105. A total of 40 filers reported holding CORREVIO PHARMA CORP in Q1 2019. The put-call ratio across all filers is 2.68 and the average weighting 0.9%.

Quarter-by-quarter ownership
Tamarack Advisers, LP ownership history of CORREVIO PHARMA CORP
ValueSharesWeighting
Q4 2019$1,019,000
-88.7%
2,500,000
-44.4%
0.23%
-90.1%
Q3 2019$9,000,000
+21.0%
4,500,000
+34.3%
2.34%
+3.7%
Q2 2019$7,437,000
-1.9%
3,350,000
+39.6%
2.26%
-24.9%
Q1 2019$7,584,000
+43.3%
2,400,000
+12.9%
3.01%
+39.5%
Q4 2018$5,291,000
-36.1%
2,125,000
+3.2%
2.16%
-8.7%
Q3 2018$8,281,000
+9.5%
2,060,000
+3.0%
2.36%
-6.6%
Q2 2018$7,560,0002,000,0002.53%
Other shareholders
CORREVIO PHARMA CORP shareholders Q1 2019
NameSharesValueWeighting ↓
SUMMER ROAD LLC 250,000$103,0000.68%
Tamarack Advisers, LP 2,500,000$1,019,0000.23%
Virtu Financial LLC 287,972$118,0000.01%
ARS Investment Partners, LLC 147,818$61,0000.01%
Pacifica Partners Inc. 2,665$1,0000.00%
OXFORD ASSET MANAGEMENT LLP 116,653$48,0000.00%
K.J. Harrison & Partners Inc 12,860$5,0000.00%
TORONTO DOMINION BANK 153$00.00%
SCOTIA CAPITAL INC. 19,000$8,0000.00%
MORGAN STANLEY 99,852$41,0000.00%
View complete list of CORREVIO PHARMA CORP shareholders